Publications by authors named "Douglas D Richman"

Claim this Profile
C
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapy.
Sonia Bakkour Coco, Mars Stone, Xutao Deng, Yunfei Wang, Wes Rountree, Douglas D Richman

J Clin Microbiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance.
Annemarie M Wensing, Charlotte Charpentier, Vincent Calvez, Francesca Ceccherini-Silberstein, Huldrych F Günthard, Douglas D Richman

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 update of the drug resistance mutations in HIV-1.
Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Huldrych F Günthard, Douglas D Richman

Top Antivir Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on data sharing in HIV drug resistance research.
Seth C Inzaule, Mark J Siedner, Susan J Little, Santiago Avila-Rios, Alisen Ayitewala, Douglas D Richman

PLoS Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection.
Sunil K Ahuja, Muthu Saravanan Manoharan, Grace C Lee, Lyle R McKinnon, Justin A Meunier, Douglas D Richman

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2022 update of the drug resistance mutations in HIV-1.
Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Huldrych F Günthard, Douglas D Richman

Top Antivir Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency.
Nadejda Beliakova-Bethell, Antigoni Manousopoulou, Savitha Deshmukh, Amey Mukim, Douglas D Richman

Virology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process.
João Marques-Gomes, Matthew J Salt, Rita Pereira-Neto, Franca S Barteldes, Vera Gouveia-Barros, Douglas D Richman

HIV Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is France Once Again Looking for a Scapegoat?
Michael M Lederman, Jeffrey S Flier, Peter Hale, Ashley T Haase, William Powderly, Douglas D Richman

Pathog Immun· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic resilience and COVID-19 survival advantage.
Grace C Lee, Marcos I Restrepo, Nathan Harper, Muthu Saravanan Manoharan, Alisha M Smith, Douglas D Richman

J Allergy Clin Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
Mars Stone, Daniel I S Rosenbloom, Peter Bacchetti, Xutao Deng, Melanie Dimapasoc, Douglas D Richman

J Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disregarding drug resistance mutations without peril.
Douglas D Richman

AIDS· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccines: implementation, limitations and opportunities.
Douglas D Richman

Glob Health Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy.
Sonia Bakkour, Xutao Deng, Peter Bacchetti, Eduard Grebe, Leilani Montalvo, Douglas D Richman

J Clin Microbiol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents.
Thomas Vollbrecht, Aaron O Angerstein, Bryson Menke, Nikesh M Kumar, Michelli Faria de Oliveira, Douglas D Richman

Retrovirology· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral Drug Discovery To Address the COVID-19 Pandemic.
Douglas D Richman

mBio· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.
Lucas E Hermans, Sergio Carmona, Monique Nijhuis, Hugo A Tempelman, Douglas D Richman

PLoS Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2019 update of the drug resistance mutations in HIV-1.
Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Huldrych F Günthard, Douglas D Richman

Top Antivir Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Ambrosioni et al.
Huldrych F Günthard, Vincent Calvez, Roger Paredes, Deenan Pillay, Robert W Shafer, Douglas D Richman

Clin Infect Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation.
Nadejda Beliakova-Bethell, Amey Mukim, Cory H White, Savitha Deshmukh, Hosiana Abewe, Douglas D Richman

J Biol Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.
Daniel I S Rosenbloom, Peter Bacchetti, Mars Stone, Xutao Deng, Ronald J Bosch, Douglas D Richman

PLoS Comput Biol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV.
Douglas D Richman, Karissa Huang, Steven M Lada, Xiaoying Sun, Sonia Jain

Retrovirology· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.
Huldrych F Günthard, Vincent Calvez, Roger Paredes, Deenan Pillay, Robert W Shafer, Douglas D Richman

Clin Infect Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR.
Steven M Lada, Karissa Huang, D Jake VanBelzen, Luis J Montaner, Una O'Doherty, Douglas D Richman

J Clin Microbiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved assays to measure and characterize the inducible HIV reservoir.
Marta Massanella, Christina Yek, Steven M Lada, Masato Nakazawa, Neda Shefa, Douglas D Richman

EBioMedicine· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis